Source: StreetInsider

Press Release: Precision BioLogic : Precision BioLogic's Factor VIII Deficient Plasma with VWF Now FDA-Cleared for Sale in U.S.

HALIFAX, NS, Sept. 18, 2023 /PRNewswire/ -...

Read full article »
Precision BioLogic's Competitors | Precision BioLogic's News | Precision BioLogic's Financials
Stay up-to-date with the latest news on Precision BioLogic
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Paul Empey's photo - President & CEO of Precision BioLogic

President & CEO

Paul Empey

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Precision BioLogic